NYSE · Healthcare
Pediatrix Medical Group, Inc. (MD)
As-reported financials and recent SEC filings for Pediatrix Medical Group, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.91B
Net income
$165.4M
Net margin
8.6%
Diluted EPS
$1.94
ROE
19.1%
P/E (TTM)
12.0×
Market cap
$2.03B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B |
| Gross profit | — | — | — | — | — |
| Operating income | $208.8M | $-68.7M | $7.3M | $172.7M | $202.9M |
| Net income | $165.4M | $-99.1M | $-60.4M | $66.3M | $131.0M |
| Diluted EPS | $1.94 | $-1.19 | $-0.73 | $0.79 | $1.53 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-24
View on EDGAR →32026-06-24
View on EDGAR →42026-06-10
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →S-82026-05-21
View on EDGAR →Go deeper on MD
Search Pediatrix Medical Group, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.